The extrinsic hysteresis behavior of dilute binary ferrofluids

Abstract

We report on the magnetization behavior of dilute binary ferrofluids based on γ-Fe(2)O(3)/Ni(2)O(3) composite nanoparticles (A particles), with diameter about 11 nm, and ferrihydrite (Fe(5)O(7)(OH) ・4H2O) nanoparticles (B particles), with diameter about 6 nm. The results show that for the binary ferrofluids with A-particle volume fraction φ(A) = 0.2% and B-particle volume fractions φ(B) = 0.1% and φ(B) = 0.6%, the magnetization curves exhibit quasi-magnetic hysteresis behavior. The demagnetizing curves coincide with the magnetizing curves at high fields. However, for single γ-Fe(2)O(3)/Ni(2)O(3) ferrofluids with φ(A) = 0.2% and binary ferrofluids with φ(A) = 0.2% and φ(B) = 1.0%, the magnetization curves do not behave in this way. Additionally, at high field (750 kA/m), the binary ferrofluid with φ(B) = 1.0% has the smallest magnetization. From the model-of-chain theory, the extrinsic hysteresis behavior of these samples is attributed to the field-induced effects of pre-existing A particle chains, which involve both Brownian rotation of the chains'moments and a Néel rotation of the particles' moments in the chains. The loss of magnetization for the ferrofluids with φ(B) = 1.0% is attributed to pre-existing ring-like A-particle aggregates. These magnetization behaviors of the dilute binary ferrofluids not only depend on features of the strongly magnetic A-particle system, but also modifications of the weaker magnetic B-particle system.

Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles

“…[11][12][13] As these particles are shed into virtually every biological fluid and embody a good representation of their parent cell, analysis of the EV cargo has great potential for biomarker discovery and disease diagnosis. 14,15 Notably, researchers have also found many differentiating characteristics of the cancer cell-derived cargo including driver mutations, molecular subtypes, active miRNA, and proteins, which possess metastatic properties and have been shown to prepare the premetastatic niche. [16][17][18][19][20][21][22][23] Particularly promising are the findings that these EV-based disease markers can be identified well before the onset of symptoms or physiological detection of a tumor, making them promising candidates for early stage cancer and other disease detection.…”